Clinical Trial Update: Antiepileptic Efficacy Study of GWP42003-P in Children and Young Adults With Dravet Syndrome (GWPCARE1) [Phase 3]

View source ↗

Summary

Phase 3 trial update on GWP42003-P in children and young adults with Dravet syndrome. Completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dravet Syndrome
• Epilepsy

Drugs mentioned

• GWP42003-P

Snippet

Sponsor: Jazz Pharmaceuticals | Conditions: Epilepsy, Dravet Syndrome | Phase 3 | Status: COMPLETED | Results posted: 2018-07-20